|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +0.09% |
|
-.--% | +159.10% |
| 06-16 | Assertio Holdings Completes Merger With Zydus Lifesciences | MT |
| 06-16 | Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 | CI |
| Market Cap | 152M 133M 123M 113M 215M 14.5B 219M 1.47B 575M 7.12B 570M 558M 24.66B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 129M 113M 104M 96.07M 182M 12.29B 185M 1.24B 487M 6.03B 483M 473M 20.9B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.57% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Assertio Holdings
| 1 day | +0.09% | ||
| 1 month | +0.17% | ||
| 3 months | +30.41% | ||
| 6 months | +155.71% | ||
| Current year | +159.10% |
| 1 month | 23.47 |  | 23.5 |
| Current year | 9.11 | | 23.5 |
| 1 year | 8.61 | | 23.5 |
| 3 years | 7.71 | | 86.7 |
| 5 years | 7.71 | | 120.15 |
| 10 years | 7.71 | | 1,621.19 |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 2026-06-15 |
Punit Patel
BRD | Director/Board Member | - | 2026-06-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-15 | Tender | Chief Financial Officer | -124,840 | 1.9319% | ||
| 06-15 | Tender | Director | -36,438 | 0.5639% | ||
| 06-15 | Tender | General Counsel | -108,771 | 1.6832% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -.--% | +127.88% | -70.22% | 152M | |
| +0.09% | +0.25% | +54.65% | +169.19% | 1,085B | |
| -1.63% | -1.50% | +65.79% | +62.70% | 624B | |
| -1.12% | -4.27% | +31.10% | +84.44% | 442B | |
| +0.86% | -0.62% | +28.71% | +27.62% | 332B | |
| -1.71% | -8.99% | +23.81% | +29.23% | 277B | |
| +0.68% | -2.20% | +26.10% | +45.84% | 282B | |
| +0.30% | -2.05% | -29.71% | -39.69% | 217B | |
| -1.19% | -2.81% | +22.63% | +66.30% | 196B | |
| -0.72% | +2.72% | +19.07% | +81.19% | 167B | |
| Average | -0.31% | -1.65% | +37.00% | +45.66% | 362.21B | |
| Weighted average by Cap. | -0.25% | -1.06% | +38.31% | +85.08% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 400K 350K 323K 299K 567K 38.18M 576K 3.86M 1.51M 18.75M 1.5M 1.47M 64.95M | - |
| Net Debt | - | - |
Employees
53
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASRT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
